Exploiting noncovalent interactions in an imine-based covalent organic 
framework for quercetin delivery

Vyas, Vijay S.; Vishwakarma, Medhavi; Moudrakovski, Igor; Haase, Frederick; Savasci, Gökcen; Ochsenfeld, Christian; Spatz, Joachim P.; Lotsch, Bettina V.

doi:10.1002/adma.201603006

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Exploiting noncovalent interactions in an imine-based covalent organic framework for quercetin delivery

MPS-Authors

/persons/resource/persons201339

Vishwakarma, Medhavi
Cellular Biophysics, Max Planck Institute for Medical Research, Max Planck Society;
Biophysical Chemistry, Institute of Physical Chemistry, University of Heidelberg, 69120 Heidelberg, Germany;

/persons/resource/persons76135

Spatz, Joachim P.
Cellular Biophysics, Max Planck Institute for Medical Research, Max Planck Society;
Biophysical Chemistry, Institute of Physical Chemistry, University of Heidelberg, 69120 Heidelberg, Germany;

External Resource

http://onlinelibrary.wiley.com/doi/10.1002/adma.201603006/epdf
(Any fulltext)

https://dx.doi.org/10.1002/adma.201603006
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Vyas, V. S., Vishwakarma, M., Moudrakovski, I., Haase, F., Savasci, G., Ochsenfeld, C., et al. (2016). Exploiting noncovalent interactions in an imine-based covalent organic framework for quercetin delivery. Advanced Materials Interfaces, 28(39), 8749-8754. doi:10.1002/adma.201603006.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002C-45F4-9

Abstract

Covalent organic frameworks (COFs) are a new class of nanoporous polymeric vector showing promise as drug-delivery vehicles with high loading capacity and biocompatibility. The interaction between the carrier and the cargo is specifically tailored on a molecular level by H-bonding. Cell-proliferation studies indicate higher efficacy of the drug in cancer cells by nanocarrier delivery mediated by the COF.